Cellini B, Baum M, Frishberg Y, Groothoff J, Harris P, Hulton S
Kidney Int Rep. 2024; 9(11):3083-3096.
PMID: 39534212
PMC: 11551133.
DOI: 10.1016/j.ekir.2024.08.031.
Huang Y, Zhu W, Zhou J, Huang Q, Zeng G
Biomolecules. 2024; 14(5).
PMID: 38785918
PMC: 11117870.
DOI: 10.3390/biom14050511.
Rather J, Rasheed R, Wani M, Bhat M, Wani I
J Med Case Rep. 2023; 17(1):421.
PMID: 37803380
PMC: 10559408.
DOI: 10.1186/s13256-023-04129-z.
Sas D, Harris P, Milliner D
Urolithiasis. 2018; 47(1):79-89.
PMID: 30535828
DOI: 10.1007/s00240-018-1093-3.
Fargue S, Milliner D, Knight J, Olson J, Lowther W, Holmes R
J Am Soc Nephrol. 2018; 29(6):1615-1623.
PMID: 29588429
PMC: 6054332.
DOI: 10.1681/ASN.2017040390.
Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
Konkolova J, Chandoga J, Kovacik J, Repisky M, Kramarova V, Paucinova I
BMC Med Genet. 2017; 18(1):59.
PMID: 28569194
PMC: 5452357.
DOI: 10.1186/s12881-017-0421-8.
Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.
Pelle A, Cuccurullo A, Mancini C, Sebastiano R, Stallone G, Negrisolo S
J Nephrol. 2016; 30(2):219-225.
PMID: 26946417
DOI: 10.1007/s40620-016-0287-4.
Primary hyperoxalurias: diagnosis and treatment.
Ben-Shalom E, Frishberg Y
Pediatr Nephrol. 2014; 30(10):1781-91.
PMID: 25519509
DOI: 10.1007/s00467-014-3030-1.
Genetic determinants of urolithiasis.
Monico C, Milliner D
Nat Rev Nephrol. 2011; 8(3):151-62.
PMID: 22183508
PMC: 3901084.
DOI: 10.1038/nrneph.2011.211.
Primary cultures of renal proximal tubule cells derived from individuals with primary hyperoxaluria.
Price K, Hulton S, Vant Hoff W, Masters J, Rumsby G
Urol Res. 2009; 37(3):127-32.
PMID: 19283374
DOI: 10.1007/s00240-009-0185-5.
Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design.
Murray M, Holmes R, Lowther W
Biochemistry. 2008; 47(8):2439-49.
PMID: 18215067
PMC: 2683390.
DOI: 10.1021/bi701710r.
A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2.
Takayama T, Nagata M, Ozono S, Nonomura K, Cramer S
Nephrol Dial Transplant. 2007; 22(8):2371-4.
PMID: 17510093
PMC: 2413148.
DOI: 10.1093/ndt/gfm271.
Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II.
Schulze M, Wachter R, Schmeisser A, Fischer R, Strasser R
Clin Res Cardiol. 2006; 95(4):235-40.
PMID: 16598594
DOI: 10.1007/s00392-006-0362-2.
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
Knight J, Holmes R, Milliner D, Monico C, Cramer S
Nephrol Dial Transplant. 2006; 21(8):2292-5.
PMID: 16597637
PMC: 1579247.
DOI: 10.1093/ndt/gfl142.
Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.
Behnam J, Williams E, Brink S, Rumsby G, Danpure C
Biochem J. 2005; 394(Pt 2):409-16.
PMID: 16309382
PMC: 1408671.
DOI: 10.1042/BJ20051397.
The many roles of oxalate in nature.
Smith L
Trans Am Clin Climatol Assoc. 2002; 113:1-20.
PMID: 12053702
PMC: 2194490.
A new case of hyperoxaluria type II.
Vilarinho L, Araujo R, Vilarinho A, Pereira E, Abdo K, Bardet J
J Inherit Metab Dis. 1993; 16(5):896-7.
PMID: 8295409
DOI: 10.1007/BF00714287.
Hyperoxaluria and renal calculi.
Woolfson R, Mansell M
Postgrad Med J. 1994; 70(828):695-8.
PMID: 7831162
PMC: 2397769.
DOI: 10.1136/pgmj.70.828.695.
Ophthalmic manifestations of primary oxalosis.
Fielder A, Garner A, Chambers T
Br J Ophthalmol. 1980; 64(10):782-8.
PMID: 7426550
PMC: 1043817.
DOI: 10.1136/bjo.64.10.782.
Primary hyperoxaluria.
ORegan P, JOEKES A
J R Soc Med. 1980; 73(8):541-4.
PMID: 7014893
PMC: 1437844.
DOI: 10.1177/014107688007300801.
